Kawata Takumi, Nakamura Shunsuke, Nakayama Akihiro, Fukuda Hiroyuki, Ebara Masaaki, Nagamine Takeaki, Minami Takeshi, Sakurai Hiromu
Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University, Japan.
Biol Pharm Bull. 2006 Mar;29(3):403-9. doi: 10.1248/bpb.29.403.
It is desirable to diagnose hepatocellular carcinoma (HCC) in the early stages during its development since its treatment is usually difficult. We previously proposed a new diagnostic method that made use of the total metallothionein (MT), zinc (Zn), and copper (Cu) concentrations in the liver of the HCC patients. We recently found that MT-1 is involved in the metabolism or detoxification of toxic metals, such as cadmium; on the other hand, MT-2 is responsible for the homeostasis of essential metals such as copper, in experimental models such as Long Evans Cinnamon (LEC) rats. In order to device a better diagnostic method than the one we proposed previously, in this study, we newly propose an improved method that includes the discriminative determination data regarding the MT isomers, namely, MT-1 and MT-2, in the liver of patients with or without HCC as compared with the total MT level. The total MT and Zn concentrations in the HCC patients were confirmed to be significantly lower than those in patients without hepatic disorders (Ctrl). In contrast, Cu concentrations of the HCC patients were higher than those of the Ctrl patients. In addition, in the juxta-tumor portion with HCC, MT-1 concentrations were significantly higher than those of MT-2. In contrast, the MT-1 concentrations in the tumor portion were significantly lower than that in the juxta-tumor portion. In addition, MT-1/MT-2 ratio in the tumor portion was significantly lower than that of the juxta-tumor portion. By using parameters such as concentrations of Cu, Zn, total MT, and MT isomers, we performed the multivariate discriminative analysis (MDA). The results suggest that the concentrations of MT isomers change depending on the progress of the tumor, and information on MT isomers and trace elements is very useful in determining the stage of the chronic hepatic disorder.
由于肝细胞癌(HCC)的治疗通常很困难,因此在其发展的早期阶段进行诊断是很有必要的。我们之前提出了一种新的诊断方法,该方法利用了HCC患者肝脏中总金属硫蛋白(MT)、锌(Zn)和铜(Cu)的浓度。我们最近发现,在Long Evans Cinnamon(LEC)大鼠等实验模型中,MT-1参与了镉等有毒金属的代谢或解毒;另一方面,MT-2负责铜等必需金属的稳态。为了设计出一种比我们之前提出的方法更好的诊断方法,在本研究中,我们新提出了一种改进方法,该方法包括与总MT水平相比,对HCC患者或非HCC患者肝脏中MT异构体(即MT-1和MT-2)的鉴别测定数据。HCC患者的总MT和Zn浓度被证实显著低于无肝脏疾病的患者(对照组)。相比之下,HCC患者的Cu浓度高于对照组患者。此外,在HCC的肿瘤旁部分,MT-1浓度显著高于MT-2。相反,肿瘤部分的MT-1浓度显著低于肿瘤旁部分。此外,肿瘤部分的MT-1/MT-2比值显著低于肿瘤旁部分。通过使用Cu、Zn、总MT和MT异构体浓度等参数,我们进行了多变量判别分析(MDA)。结果表明,MT异构体的浓度随肿瘤进展而变化,MT异构体和微量元素的信息在确定慢性肝病阶段非常有用。